AptaBio Therapeutics Inc. (KOSDAQ:293780)
6,460.00
+190.00 (3.03%)
Sep 23, 2026, 3:30 PM KST
| Market Cap | 181.48B -19.0% |
| Revenue (ttm) | 4.75B +52.9% |
| Net Income | -14.87B |
| EPS | -540.63 |
| Shares Out | 28.09M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 31,701 |
| Open | 6,270.00 |
| Previous Close | 6,270.00 |
| Day's Range | 6,270.00 - 6,480.00 |
| 52-Week Range | 3,870.00 - 10,890.00 |
| Beta | 0.98 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |